| Ray M, Salgia R, Vokes EE
The Role of EGFR Inhibition in the Treatment of Non-Small Cell Lung Cancer. [JOURNAL ARTICLE]
Oncologist 2009 Nov 5.
Abstract | Full Citation | Find Related Articles | | Levchenko EV, Moiseyenko VM, Matsko DE, et al.
Down-staging of EGFR mutation-positive advanced lung carcinoma with gefitinib followed by surgical intervention: follow-up of two cases. [Journal Article, Research Support, Non-U.S. Gov't]
Onkologie 2009 Nov; 32(11):674-7.
Abstract | Full Citation | | Kanda S, Naba A, Miyata Y
Inhibition of endothelial cell chemotaxis toward FGF-2 by gefitinib associates with downregulation of Fes activity. [JOURNAL ARTICLE]
Int J Oncol 2009 Dec; 35(6):1305-1312.
Abstract | Full Citation | | Lara-Guerra H, Waddell TK, Salvarrey MA, et al.
Phase II Study of Preoperative Gefitinib in Clinical Stage I Non-Small-Cell Lung Cancer. [JOURNAL ARTICLE]
J Clin Oncol 2009 Nov 2.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Nishimura H, Nakajima T, Itakura M, et al.
Successful treatment of lung cancer with gefitinib and EGFR mutation status determination using EBUS-TBNA samples in an extremely old patient. [Journal Article, Research Support, Non-U.S. Gov't]
Intern Med 2009; 48(21):1905-7.
Abstract | Full Citation | | Van Waes C, Allen CT, Citrin D, et al.
Molecular and Clinical Responses in a Pilot Study of Gefitinib with Paclitaxel and Radiation in Locally Advanced Head-and-Neck Cancer. [JOURNAL ARTICLE]
Int J Radiat Oncol Biol Phys 2009 Oct 29.
Abstract | Full Citation | Find Related Articles | | Gridelli C, Maione P, Rossi A, et al.
Treatment of advanced non-small-cell lung cancer in the elderly. [JOURNAL ARTICLE]
Lung Cancer 2009 Oct 28.
Abstract | Full Citation | Find Related Articles | | Chahbouni A, den Burger JC, Vos RM, et al.
Simultaneous Quantification of Erlotinib, Gefitinib, and Imatinib in Human Plasma by Liquid Chromatography Tandem Mass Spectrometry. [JOURNAL ARTICLE]
Ther Drug Monit 2009 Oct 27.
Abstract | Full Citation | | Roche S, McMahon G, Clynes M, et al.
Development of a high-performance liquid chromatographic-mass spectrometric method for the determination of cellular levels of the tyrosine kinase inhibitors lapatinib and dasatinib. [JOURNAL ARTICLE]
J Chromatogr B Analyt Technol Biomed Life Sci 2009 Oct 12.
Abstract | Full Citation | Find Related Articles | | Sanford M, Scott LJ
Gefitinib: a review of its use in the treatment of locally advanced/metastatic non-small cell lung cancer. [Journal Article]
Drugs 2009; 69(16):2303-28.
Abstract | Full Citation |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
